-Reuters
Rxsight Raised $50M Via Secondary Equity Offering For Commercial And Marketing Expansion, Funding Of Product Development, Research And Clinical Development
RxSight, Inc. ("RxSight"), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it has priced its underwritten public offering.
